Group 1 - The Artemisinin concept index increased by 0.65%, ranking 10th among concept sectors, with four stocks rising, including Haizheng Pharmaceutical which hit the daily limit, and Zhejiang Medicine, Huaren Shuanghe, and Baiyunshan also showing gains of 0.79%, 0.69%, and 0.08% respectively [1] - The leading decliners in the sector included Rundu Co., New Harmony, and Kunming Pharmaceutical, which fell by 1.41%, 1.36%, and 1.17% respectively [1] - The net inflow of main funds into the Artemisinin concept sector was 95 million yuan, with Haizheng Pharmaceutical receiving the highest net inflow of 105 million yuan, followed by Zhejiang Medicine, New Harmony, and Baihua Pharmaceutical with net inflows of 25.71 million yuan, 9.91 million yuan, and 2.14 million yuan respectively [2][3] Group 2 - In terms of fund inflow ratios, Haizheng Pharmaceutical, Zhejiang Medicine, and Baihua Pharmaceutical had the highest net inflow rates of 9.03%, 5.48%, and 2.27% respectively [3] - The trading performance of key stocks in the Artemisinin concept included Haizheng Pharmaceutical with a daily increase of 10.02% and a turnover rate of 9.22%, while Zhejiang Medicine rose by 0.79% with a turnover rate of 3.19% [3][4] - Other stocks such as New Harmony and Baihua Pharmaceutical experienced declines of 1.36% and 0.41% respectively, with turnover rates of 1.04% and 3.34% [3][4]

Group 1 - The Low-E glass concept increased by 2.38%, ranking 8th among concept sectors, with seven stocks rising, including Yamaton and Yaopi Glass hitting the daily limit [1] - Notable gainers in the Low-E glass sector include Wanshun New Materials, which rose by 7.18%, and Xinsai Co., which increased by 1.37% [1] - The sector experienced a net outflow of 0.25 billion yuan in main funds, with Wanshun New Materials receiving the highest net inflow of 46.49 million yuan [2][3] Group 2 - The main fund inflow ratios for leading stocks in the Low-E glass sector are as follows: Yamaton at 52.06%, Hainan Development at 10.65%, and Wanshun New Materials at 6.50% [3] - The trading performance of key stocks includes: Wanshun New Materials up by 7.18% with a turnover rate of 16.63%, Yamaton up by 10.02% with a turnover rate of 1.29%, and Hainan Development up by 0.21% with a turnover rate of 2.82% [3][4] - Decliners in the sector include Nanbo A, which fell by 0.83%, and Sanxia New Materials, which decreased by 0.30% [1][4]

（原标题：数据复盘丨医药生物、银行等行业走强 54股获主力资金净流入超1亿元） 7月1日，上证指数早盘探底回升，随后有所回落，临近午盘再度回升，午后震荡上扬；深证成指、创业板指早盘低开低走，午后震荡回升；科创 50指数全天震荡走低。截至收盘，上证指数报3457.75点，涨0.39%，成交额5535.57亿元；深证成指报10476.29点，涨0.11%，成交额9124.79亿 元；创业板指报2147.92点，跌0.24%，成交额4444.96亿元；科创50指数报994.80点，跌0.86%，成交额280.4亿元。沪深两市合计成交14660.36亿 元，成交额较上一交易日减少208.48亿元。 医药生物、银行等行业走强 诚邦股份4连板 盘面上来看，行业板块、概念涨多跌少。其中，医药生物、银行、教育、有色金属、公用事业、建筑材料、钢铁、化工等行业涨幅靠前；创新 药、可控核聚变、重组蛋白、维生素、合成生物、人脑工程、钛白粉、黄金、宠物经济等概念走势活跃。计算机、商贸零售、通信、传媒、证券 等行业跌幅居前；数字货币、跨境支付、铜缆高速连接、盲盒经济、国产软件等概念走势较弱。涨停个股主要集中在医药生物、化工、电子、机 械 ...

资金面上看，今日重组蛋白概念板块获主力资金净流入6.45亿元，其中，26股获主力资金净流入，5股 主力资金净流入超5000万元，净流入资金居首的是一品红，今日主力资金净流入1.68亿元，净流入资金 居前的还有科兴制药、热景生物、贝达药业等，主力资金分别净流入9780.36万元、8241.33万元、 8182.93万元。 （原标题：6.45亿主力资金净流入，重组蛋白概念涨3.00%） 截至7月1日收盘，重组蛋白概念上涨3.00%，位居概念板块涨幅第4，板块内，43股上涨，未名医药涨 停，科兴制药、一品红、热景生物等涨幅居前，分别上涨15.62%、14.72%、11.60%。跌幅居前的有*ST 苏吴、东星医疗、成大生物等，分别下跌0.79%、0.40%、0.30%。 今日涨跌幅居前的概念板块 | 概念 | 今日涨跌幅（%） | 概念 | 今日涨跌幅（%） | | --- | --- | --- | --- | | 中船系 | 4.90 | 电子身份证 | -2.52 | | 细胞免疫治疗 | 3.12 | 数字货币 | -2.40 | | 创新药 | 3.01 | 跨境支付(CIPS) | -1.77 | | 重 ...

Market Performance - As of June 26, the DRG/DIP concept index rose by 1.97%, ranking fifth among concept sectors, with 16 stocks increasing in value [1] - Notable gainers included Kechuang Information, which hit a 20% limit up, and Huayu Software, Guoxin Health, and Digital Certification, which rose by 4.75%, 3.69%, and 3.50% respectively [1] - The sectors with the highest and lowest daily performance included the Military Equipment Restructuring concept at +8.73% and the Photolithography Machine concept at -1.48% [1] Capital Flow - The DRG/DIP concept sector saw a net inflow of 412 million yuan, with 14 stocks receiving net inflows, and 5 stocks attracting over 30 million yuan each [1] - Kechuang Information led the net inflow with 205 million yuan, followed by Guoxin Health, Huayu Software, and Digital Certification with net inflows of 69.67 million yuan, 64.82 million yuan, and 47.87 million yuan respectively [1] - The top three stocks by net inflow ratio were Kechuang Information at 20.10%, Guoxin Health at 13.05%, and Huayu Software at 11.15% [2]

截至6月17日收盘，可燃冰概念上涨3.34%，位居概念板块涨幅第2，板块内，9股上涨，新锦动力、海 默科技、泰山石油等涨幅居前，分别上涨16.77%、13.97%、3.56%。跌幅居前的有广州发展、中集集团 等，分别下跌0.75%、0.26%。 资金面上看，今日可燃冰概念板块获主力资金净流出1.22亿元，其中，6股获主力资金净流入，5股主力 资金净流入超千万元，净流入资金居首的是石化油服，今日主力资金净流入9027.33万元，净流入资金 居前的还有新锦动力、神开股份、中集集团等，主力资金分别净流入3737.70万元、2888.51万元、 2208.23万元。 资金流入比率方面，石化油服、中集集团、神开股份等流入比率居前，主力资金净流入率分别为 12.81%、10.39%、4.96%。（数据宝） | 601808 | 中海油 | 2.12 | 1.38 | -84.95 | -0.15 | | --- | --- | --- | --- | --- | --- | | | 服 | | | | | | 000852 | 石化机 械 | 0.58 | 4.65 | -186.00 | -0.62 | | 30019 ...

Group 1 - The horse racing concept index increased by 1.32%, ranking 10th among concept sectors, with four stocks rising, including Zhujiang Piano which hit the daily limit, and Zhongmu Co., *ST Zhengping, and Luoniushan showing gains of 2.86%, 0.58%, and 0.50% respectively [1] - The main funds in the horse racing concept sector experienced a net outflow of 0.19 billion yuan, with Zhujiang Piano leading the net inflow at 21.32 million yuan, followed by Luoniushan, Zhongmu Co., and *ST Zhengping with net inflows of 7.99 million yuan, 4.25 million yuan, and 3.48 million yuan respectively [2][3] - The net inflow ratios for Zhujiang Piano, Luoniushan, and *ST Zhengping were 11.33%, 4.19%, and 3.37% respectively, indicating strong interest from main funds [3] Group 2 - The horse racing concept sector had a total of four stocks that rose, while Zhongti Industry and Xinhua Du were among the top decliners, falling by 2.52% and 2.17% respectively [1][2] - The trading volume and turnover rates for the leading stocks in the horse racing concept were notable, with Zhujiang Piano showing a turnover rate of 2.27% and a significant net inflow of funds [3]

截至6月17日收盘，重组蛋白概念下跌2.05%，位居概念板块跌幅榜前列，板块内，科兴制药、一品 红、赛升药业等跌幅居前，股价上涨的有10只，涨幅居前的有智飞生物、华北制药、未名医药等，分别 上涨4.76%、4.61%、2.07%。 | 688553 | 汇宇制药 | -2.94 | 2.43 | -1202.52 | | --- | --- | --- | --- | --- | | 600645 | 中源协和 | -1.63 | 2.20 | -1191.30 | | 301080 | 百普赛斯 | -4.54 | 3.41 | -591.08 | | 688179 | 阿拉丁 | -1.83 | 2.16 | -474.18 | | 000813 | 德展健康 | -0.90 | 2.07 | -446.55 | | 002581 | 未名医药 | 2.07 | 6.91 | -352.83 | | 000638 | *ST万方 | -0.40 | 2.63 | -343.34 | | 688253 | 英诺特 | 1.13 | 1.86 | -324.32 | | 301371 | 敷尔佳 | -1.1 ...

Group 1 - The recombinant protein concept sector declined by 0.82%, ranking among the top declines in concept sectors, with notable declines in companies such as Kexing Pharmaceutical, Jieya Co., and Yipinhong [1] - Among the 14 stocks that rose, Furuida, Borui Pharmaceutical, and Saiseng Pharmaceutical had the highest increases of 10.06%, 3.54%, and 2.90% respectively [1] - The sector experienced a net outflow of 232 million yuan from main funds, with 35 stocks seeing net outflows, and five stocks experiencing outflows exceeding 30 million yuan [2] Group 2 - The top net outflow stock was Saiseng Pharmaceutical, with a net outflow of 65.48 million yuan, followed by Xilong Science, Zhongyuan Qihe, and Borui Pharmaceutical with net outflows of 61.32 million yuan, 53.12 million yuan, and 51.87 million yuan respectively [2][3] - The stocks with the highest net inflows included Furuida, Maiwei Bio, and Ruizhi Pharmaceutical, with net inflows of 189 million yuan, 39.29 million yuan, and 18.25 million yuan respectively [2] - The trading volume and price changes of various stocks in the recombinant protein sector indicate significant market activity, with Saiseng Pharmaceutical showing a trading rate of 35.58% despite the outflow [3]

Market Overview - The Shanghai Composite Index closed at 3384.82 points, down 0.44%, with a trading volume of 557.43 billion yuan [1] - The Shenzhen Component Index closed at 10162.18 points, down 0.86%, with a trading volume of 857.95 billion yuan [1] - The ChiNext Index closed at 2037.27 points, down 1.17%, with a trading volume of 411.80 billion yuan [1] - The total trading volume of both markets was 1415.37 billion yuan, an increase of 128.96 billion yuan compared to the previous trading day [1] Sector Performance - Strong sectors included beauty care, biomedicine, and banking, while sectors like defense, computer, electronics, and communication saw declines [2] - The beauty care and biomedicine sectors showed significant gains, with ST United achieving nine consecutive limit-up trading days [5] - A total of 1175 stocks rose, while 3857 stocks fell, with 62 stocks hitting the limit-up and 2 stocks hitting the limit-down [2] Fund Flow Analysis - The net outflow of main funds from the two markets was 35.97 billion yuan, with the ChiNext experiencing a net outflow of 16.83 billion yuan [6] - Six sectors saw net inflows, with transportation leading at 320 million yuan, followed by public utilities and real estate [6] - A total of 2015 stocks experienced net inflows, with 26 stocks receiving over 100 million yuan in net inflows, led by Zhongke Shuguang with 569 million yuan [8] Individual Stock Highlights - Zhongke Shuguang had the highest limit-up order volume at 50.39 million shares, followed by Ningbo Shipping and Yiming Pharmaceutical [2] - The top stocks by net inflow included Zhongke Shuguang (1.98 billion yuan), Yiming Pharmaceutical (416 million yuan), and Ningbo Shipping (257 million yuan) [10] - The most significant net outflows were seen in Dongfang Wealth (768 million yuan) and Langchao Information (549 million yuan) [12] Institutional Activity - Institutions had a net sell of approximately 212 million yuan, with the highest net buy in Fuchun Co. at 48.92 million yuan [15] - The top net selling stocks included Kuaijingtong and Guangkang Biochemical, with net sells of 1.19 billion yuan and 1.05 billion yuan respectively [15]